Solstice Capital seeks superior venture capital returns for its limited partners through investments in seed- and early-stage companies in
Solstice Capital seeks superior venture capital returns for its limited partners through investments in seed- and early-stage companies in the industry areas of alternative energy, education, the environment, life sciences and information technology. Solstice's unique assets give it a distinct advantage: a seasoned management team with over 90 years of experience in both venture investing and operations in high-growth companiesan emphasis on positive impact investingthe appropriate size fund for early-stage companiesgeographic diversification From its inception, Solstice has demonstrated its commitment to provide both capital and expert guidance to assist portfolio companies as they deal with the challenges and opportunities of growth. An early-stage, diversified, positive impact venture fund Solstice is committed to investing 50% of its capital in information technology and 50% in the following socially responsive investment categories:Alternative EnergyThe EnvironmentLife SciencesEducation
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 13, 2011
HTG Molecular Diagnostics
|
Series D | $16.20M | Biotechnology | — |
Nov 28, 2008
HTG Molecular Diagnostics
|
Series C | $2.80M | Biotechnology | — |
Oct 8, 2007
HTG Molecular Diagnostics
|
Series C | $5.61M | Biotechnology | — |
Oct 19, 2005
HTG Molecular Diagnostics
|
Series B | $3.40M | Biotechnology | — |
Sep 17, 2003
HTG Molecular Diagnostics
|
Series A | $156K | Biotechnology | — |